Janiszewska H, Haus O, Lauda-Swieciak A, Pasińska M, Laskowski R, Szymański W, Górski B, Lubiński J
Department of Clinical Genetics, University of Medicine, Bydgoszcz, Poland.
Clin Genet. 2003 Dec;64(6):502-8. doi: 10.1046/j.1399-0004.2003.00178.x.
A group of 63 families from the Pomerania-Kujawy region were analyzed for three BRCA1 gene Polish founder mutations, 5382insC, 300T>G, and 4153delA, because of breast (BrCa) and/or ovarian cancer (OvCa) history. The analysis was carried out by multiplex polymerase chain reaction method. BRCA1 mutation was revealed in nine (14%) families: in three (33%) of hereditary BrCa and OvCa families, in three (8%) of hereditary BrCa families, and in three (21%) of hereditary OvCa families. According to risk criteria, it was revealed in 45% of high-risk families with more than three cancers, 13% of moderate-risk families with two cancers, and 8% of families with sporadic OvCa. In six families, the mutation was found in a proband with BrCa or OvCa and in three families, the mutation was found in a healthy proband, first-degree relative of a patient deceased of BrCa or OvCa. 5382insC frameshift mutation accounted for 67% and 300T>G missense mutation for 33% of all identified familial mutations. 4153delA frameshift mutation was not found in analyzed sample of families. 5382insC mutation was found in 9% and 300T>G in 5% of all investigated families, and in 27 and 18%, respectively, of high-risk families. This underlines the importance of applying strict inclusion criteria to analyze mutation frequency in hereditary BrCa/OvCa families.
由于存在乳腺癌(BrCa)和/或卵巢癌(OvCa)家族病史,对来自波美拉尼亚-库亚维地区的63个家庭进行了分析,以检测三种BRCA1基因波兰始祖突变,即5382insC、300T>G和4153delA。分析采用多重聚合酶链反应方法进行。在9个(14%)家庭中发现了BRCA1突变:在遗传性BrCa和OvCa家庭中有3个(33%),在遗传性BrCa家庭中有3个(8%),在遗传性OvCa家庭中有3个(21%)。根据风险标准,在45%有三种以上癌症的高风险家庭、13%有两种癌症的中度风险家庭以及8%散发型OvCa家庭中发现了该突变。在6个家庭中,突变出现在患有BrCa或OvCa的先证者中,在3个家庭中,突变出现在健康的先证者(因BrCa或OvCa去世患者的一级亲属)中。在所有已鉴定的家族性突变中,5382insC移码突变占67%,300T>G错义突变占33%。在所分析的家庭样本中未发现4153delA移码突变。在所有调查家庭中,5382insC突变的发现率为9%,300T>G突变的发现率为5%,在高风险家庭中的发现率分别为27%和18%。这突出了应用严格纳入标准来分析遗传性BrCa/OvCa家庭中突变频率的重要性。